200 related articles for article (PubMed ID: 9453596)
1. Mucosal immunogenicity of a holotoxin-like molecule containing the serine-rich Entamoeba histolytica protein (SREHP) fused to the A2 domain of cholera toxin.
Sultan F; Jin LL; Jobling MG; Holmes RK; Stanley SL
Infect Immun; 1998 Feb; 66(2):462-8. PubMed ID: 9453596
[TBL] [Abstract][Full Text] [Related]
2. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.
Ryan ET; Butterton JR; Zhang T; Baker MA; Stanley SL; Calderwood SB
Infect Immun; 1997 Aug; 65(8):3118-25. PubMed ID: 9234763
[TBL] [Abstract][Full Text] [Related]
3. Oral immunization with the dodecapeptide repeat of the serine-rich Entamoeba histolytica protein (SREHP) fused to the cholera toxin B subunit induces a mucosal and systemic anti-SREHP antibody response.
Zhang T; Li E; Stanley SL
Infect Immun; 1995 Apr; 63(4):1349-55. PubMed ID: 7890393
[TBL] [Abstract][Full Text] [Related]
4. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess.
Zhang T; Stanley SL
Infect Immun; 1996 May; 64(5):1526-31. PubMed ID: 8613356
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and immunological characterization of an ETEC CFA/I adhesin cholera toxin B subunit chimera.
Jobling MG; Poole ST; Rasulova-Lewis F; O'Dowd A; McVeigh AL; Balakrishnan A; Sincock SA; Prouty MG; Holmes RK; Savarino SJ
PLoS One; 2020; 15(3):e0230138. PubMed ID: 32176708
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity of the recombinant serine rich Entamoeba histolytica protein (SREHP) amebiasis vaccine in the African green monkey.
Stanley SL; Blanchard JL; Johnson N; Foster L; Kunz-Jenkins C; Zhang T; Tian K; Cogswell FB
Vaccine; 1995 Jul; 13(10):947-51. PubMed ID: 7483769
[TBL] [Abstract][Full Text] [Related]
7. Progress towards development of a vaccine for amebiasis.
Stanley SL
Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666
[TBL] [Abstract][Full Text] [Related]
8. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin.
Carrero JC; Contreras-Rojas A; Sánchez-Hernández B; Petrosyan P; Bobes RJ; Ortiz-Ortiz L; Laclette JP
Exp Parasitol; 2010 Nov; 126(3):359-65. PubMed ID: 20303954
[TBL] [Abstract][Full Text] [Related]
9. Expression of the serine rich Entamoeba histolytica protein (SREHP) in the avirulent vaccine strain Salmonella typhi TY2 chi 4297 (delta cya delta crp delta asd): safety and immunogenicity in mice.
Zhang T; Stanley SL
Vaccine; 1997; 15(12-13):1319-22. PubMed ID: 9302737
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to the serine rich Entamoeba histolytica protein (SREHP) prevent amoebic liver abscess in severe combined immunodeficient (SCID) mice.
Zhang T; Cieslak PR; Foster L; Kunz-Jenkins C; Stanley SL
Parasite Immunol; 1994 May; 16(5):225-30. PubMed ID: 8072766
[TBL] [Abstract][Full Text] [Related]
11. Protection of gerbils from amebic liver abscess by immunization with a recombinant Entamoeba histolytica antigen.
Zhang T; Cieslak PR; Stanley SL
Infect Immun; 1994 Apr; 62(4):1166-70. PubMed ID: 8132322
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of a West Nile virus DIII-cholera toxin A2/B chimera after intranasal delivery.
Tinker JK; Yan J; Knippel RJ; Panayiotou P; Cornell KA
Toxins (Basel); 2014 Apr; 6(4):1397-418. PubMed ID: 24759174
[TBL] [Abstract][Full Text] [Related]
13. Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral immunization of mice against Helicobacter felis.
Blanchard TG; Lycke N; Czinn SJ; Nedrud JG
Immunology; 1998 May; 94(1):22-7. PubMed ID: 9708182
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.
Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY
Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220
[TBL] [Abstract][Full Text] [Related]
15. Serodiagnosis of invasive amebiasis using a recombinant Entamoeba histolytica antigen-based ELISA.
Myung K; Burch D; Jackson TF; Stanley SL
Arch Med Res; 1992; 23(2):285-8. PubMed ID: 1340316
[TBL] [Abstract][Full Text] [Related]
16. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein.
Gockel CM; Russell MW
Immunology; 2005 Dec; 116(4):477-86. PubMed ID: 16313361
[TBL] [Abstract][Full Text] [Related]
17. Fusion proteins containing the A2 domain of cholera toxin assemble with B polypeptides of cholera toxin to form immunoreactive and functional holotoxin-like chimeras.
Jobling MG; Holmes RK
Infect Immun; 1992 Nov; 60(11):4915-24. PubMed ID: 1399002
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of TcpF-A2-CTB chimera and evidence of additive protective efficacy of immunizing with TcpF and CTB in the suckling mouse model of cholera.
Price GA; Holmes RK
PLoS One; 2012; 7(8):e42434. PubMed ID: 22879984
[TBL] [Abstract][Full Text] [Related]
19. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery.
Davoodi-Semiromi A; Schreiber M; Nalapalli S; Verma D; Singh ND; Banks RK; Chakrabarti D; Daniell H
Plant Biotechnol J; 2010 Feb; 8(2):223-42. PubMed ID: 20051036
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunogenicity of a recombinant Salmonella typhimurium-cloned heterologous antigen in the absence or presence of coexpressed cholera toxin A2 and B subunits.
Harokopakis E; Hajishengallis G; Greenway TE; Russell MW; Michalek SM
Infect Immun; 1997 Apr; 65(4):1445-54. PubMed ID: 9119486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
